Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Intuitive Surgical slides as investors weigh Class I stapler-reload recall and lingering safety overhang

None

Intuitive Surgical, Inc. (ISRG) is down 5.9% today. Here is some analysis on what might have caused this price movement.

Analysis: The move appears tied to renewed investor focus on regulatory and product-safety risk after the FDA classified Intuitive’s SureForm stapler reload issue as a Class I recall. With the stock already trading under pressure following recent valuation-driven target cuts, incremental negative recall headlines can amplify downside volatility.

Details:

  • The FDA updated its communication on the SureForm 30 Gray Reloads to note the issue was classified as a Class I recall, the agency’s most serious recall category.
  • The recall communication describes a risk of incomplete staple lines in certain procedures, which can lead to serious bleeding and may require conversion to open surgery.
  • The FDA’s recall database entry for the Intuitive Surgical 8 mm SureForm 30 Gray Reloads shows a May 2026 posting and references a field safety action/recall identifier for product returns and tracking.
  • This selloff could also be exacerbated by recent analyst price-target reductions tied to valuation assumptions, which may have left sentiment fragile even after the company’s latest quarterly update.
  • Sources:

    U.S. Food and Drug Administration, Intuitive Surgical Investor Relations, Investing.com

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $ISRG Insider Trading Activity

    ISRG Insider Trades

    $ISRG insiders have traded $ISRG stock on the open market 38 times in the past 6 months. Of those trades, 0 have been purchases and 38 have been sales.

    Here’s a breakdown of recent trading of $ISRG stock by insiders over the last 6 months:

    • GARY S GUTHART has made 0 purchases and 4 sales selling 50,106 shares for an estimated $27,495,394.
    • HENRY L CHARLTON (EVP & Chief Commercial and Mkt) has made 0 purchases and 5 sales selling 13,731 shares for an estimated $7,963,980.
    • MARK BROSIUS (SVP & Chief Mfg and Supply Cha) has made 0 purchases and 8 sales selling 10,379 shares for an estimated $5,417,654.
    • MYRIAM CURET (EVP & Chief Medical Officer) has made 0 purchases and 12 sales selling 8,519 shares for an estimated $4,225,138.
    • BRIAN EDWARD MILLER (EVP & Chief Digital Officer) has made 0 purchases and 2 sales selling 3,500 shares for an estimated $2,012,500.
    • CRAIG H BARRATT sold 750 shares for an estimated $435,000
    • AMY L LADD has made 0 purchases and 2 sales selling 619 shares for an estimated $291,886.
    • FREDRIK WIDMAN (VP Corporate Controller) has made 0 purchases and 3 sales selling 500 shares for an estimated $247,744.
    • PATRICIA L WADORS (SVP Chief Human Resources Offi) sold 220 shares for an estimated $109,936

    To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

    EARLY ACCESS
    Receive ISRG Data Alerts
    Real-time alerts on filings, insider trades, and market signals — before everyone else.
    Get Alerts →

    $ISRG Hedge Fund Activity

    We have seen 1,160 institutional investors add shares of $ISRG stock to their portfolio, and 1,013 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

    $ISRG Government Contracts

    We have seen $181,000 of award payments to $ISRG over the last year.

    Here are some of the awards which we have have seen pay out the most over the last year:

    To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.

    $ISRG Congressional Stock Trading

    Members of Congress have traded $ISRG stock 4 times in the past 6 months. Of those trades, 4 have been purchases and 0 have been sales.

    Here’s a breakdown of recent trading of $ISRG stock by members of Congress over the last 6 months:

    To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

    $ISRG Analyst Ratings

    Wall Street analysts have issued reports on $ISRG in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

    Here are some recent analyst ratings:

    • BTIG issued a "Buy" rating on 01/23/2026
    • Truist Securities issued a "Buy" rating on 12/18/2025
    • RBC Capital issued a "Outperform" rating on 12/17/2025

    To track analyst ratings and price targets for $ISRG, check out Quiver Quantitative's $ISRG forecast page.

    $ISRG Price Targets

    Multiple analysts have issued price targets for $ISRG recently. We have seen 15 analysts offer price targets for $ISRG in the last 6 months, with a median target of $590.0.

    Here are some recent targets:

    • Matt Miksic from Barclays set a target price of $651.0 on 04/23/2026
    • Mike Kratky from Leerink Partners set a target price of $573.0 on 04/22/2026
    • David Rescott from Baird set a target price of $610.0 on 04/22/2026
    • Adam Maeder from Piper Sandler set a target price of $580.0 on 04/22/2026
    • Ryan Zimmerman from BTIG set a target price of $574.0 on 04/22/2026
    • Richard Newitter from Truist Securities set a target price of $580.0 on 04/15/2026
    • Anthony Petrone from Mizuho set a target price of $525.0 on 04/13/2026

    This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

    Add Quiver Quantitative to your preferred sources on Google Google News Logo

    Suggested Articles